CTKB
#2807
Cytek Biosciences, Inc. - Common Stock
4.6 2 USD
+0.02%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
+2.44%
Monthly Change
+18.16%
6 month change
-18.09%
Year Change
+40.43%
Previous Close
4.5 1
Open
4.6 2
Low
4.6 2
High
4.6 2
Volume
124
Financials
- Market Capitalization 596.64 M
- Employee 702
- Founded 1992
- CEO N/A
- Website www.cytekbio.com
- Headquarter Delaware, United States
- FIGI BBG00D36Q0Z7
- Industry Medical Devices
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-9.7
Price to sales ratio
3.2
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2772 |  TCMD Tactile Systems Technology, Inc. - Common Stock | 27.62 USD | -4.89% | -10.67% | +4.11% | +183.86% | 623.00 M USD | ||
| 2783 |  CERS Cerus Corporation - Common Stock | 3.07 USD | -0.65% | -2.85% | +20.39% | +125.74% | 615.13 M USD | ||
| 2847 |  BWAY BrainsWay Ltd - American Depositary Shares | 14.45 USD | +2.48% | -3.34% | +1.19% | +16.91% | 565.95 M USD | ||
| 2869 |  NPCE Neuropace, Inc. - Common Stock | 15.84 USD | -7.48% | -9.64% | +2.19% | +49.72% | 540.04 M USD |
Frequently asked questions about Cytek Biosciences, Inc. - Common Stock
What is the Cytek Biosciences, Inc. - Common Stock stock price today?
The current price of Cytek Biosciences, Inc. - Common Stock (CTKB) is 4.62. Over the past 24 hours, the stock has changed by +2.44%. Follow the CTKB chart for real-time price dynamics.
What is the stock ticker of Cytek Biosciences, Inc. - Common Stock?
Cytek Biosciences, Inc. - Common Stock trades under the ticker CTKB. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Cytek Biosciences, Inc. - Common Stock stock going up?
CTKB has changed by +2.67% over the last week, +18.16% over the last month, and +40.43% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Cytek Biosciences, Inc. - Common Stock net income for the last quarter?
Cytek Biosciences, Inc. - Common Stock reported net income of -18.87 M for the last quarter. The previous quarter showed -44.08 M, which means net income changed by +57.20%.
How many employees does Cytek Biosciences, Inc. - Common Stock have?
As of the latest available data, Cytek Biosciences, Inc. - Common Stock has 702 employees. Workforce size can provide additional context about the company's scale and operations.
What is Cytek Biosciences, Inc. - Common Stock EBITDA?
Cytek Biosciences, Inc. - Common Stock EBITDA is -17.05 M, and its EBITDA margin is -38.62%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Cytek Biosciences, Inc. - Common Stock stock?
You can buy Cytek Biosciences, Inc. - Common Stock (CTKB) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Cytek Biosciences, Inc. - Common Stock stock?
Investing in Cytek Biosciences, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the CTKB chart and related analysis on metatrader.com as part of your research.